Wyeth-Averst Laboratories Company | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Wyeth-Averst Laboratories Company

Sort by

Viewing results 1‒25 of 32

Special ReportRegulated Markets
Pharma dealmaking hit by greater scrutiny of prices and competition
...Li, president of Merck Research Laboratories....
February 28, 2022
US & Canadian companies
Pfizer’s Ian Read looks to count Allergan merger as his legacy
...He initially showed little interest in megamergers of the kind Pfizer carried out in the prior decade with Wyeth and Warner-Lambert....
November 27, 2015
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Pharmaceuticals sector
Business pioneer in pharmaceuticals
...They set up their own research laboratories, helping to bring scientific credibility to a fledgling industry hitherto notorious for quackery....
March 31, 2015
US & Canadian companies
No end in sight to wave of pharma dealmaking
...That was what happened in the last big round of consolidation, around the turn of the millennium, through Glaxo Wellcome’s merger with SmithKline Beecham and Pfizer’s with Warner-Lambert and Wyeth....
April 26, 2015
Person in the NewsAndrew Ward
Ian Read: the pragmatist out to transform the drugs industry
...Yet no amount of marketing could make up for the dearth of new medicines coming out of Pfizer’s laboratories....
May 2, 2014
US & Canadian companies
Drug output at heart of Pfizer deal debate
...At the heart of debate over the future of AstraZeneca is a simple question: In whose hands would the pharmaceutical company’s laboratories produce the most valuable drugs?...
May 12, 2014
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
US & Canadian companies
Big pharma deals are back in the mix
...In the five years since Pfizer bought Wyeth, it has cut about half the total research and development spending made by the two companies the year before the deal....
April 21, 2014
US & Canadian companies
Pfizer sets stage for corporate showdown
...Companies including Horizon Pharma, Perrigo, Actavis, Alkermes, Jazz Pharmaceuticals, Covidien, Forest Laboratories and Endo Health Solutions have moved to Ireland, in deals expected to cut companies’ overall...
April 28, 2014
US & Canadian companies
Nestlé ‘co-operating’ with China probe into baby milk prices
...The Beijing Times reported that Abbott Laboratories, Danone and Mead Johnson Nutrition were also involved in the probe, along with Wyeth Nutrition, now owned by Nestlé....
July 2, 2013
Andrew Jack
Pharmaceuticals: Back to the lab
...Large pharmaceutical companies expanded on the back of “blockbuster” drugs that allowed them to invest in expensive new laboratories and offices....
August 12, 2013
Pharmaceuticals sector
Pharma groups target specialised deals
...But much recent activity has instead focused on divestments, including spinoffs by Pfizer in the wake of its Wyeth purchase and by GlaxoSmithKline of some consumer products....
January 25, 2012
News in-depthThe Big Read
A sugared pill
...Isomeride, a related compound, was withdrawn in the US in 1997, triggering litigation for Wyeth, Servier’s partner, and a fresh examination of benfluorex....
March 8, 2011
US & Canadian companies
Elan chief to step down in two years
...The unit sells formulation and drug-optimisation technologies to third-party customers such as Merck, Wyeth and Abbott....
June 4, 2010
US & Canadian companies
Big pharma aims for reinvention
...For example, one rationale behind Pfizer’s takeover of Wyeth last year was to defer the pain of patent expiries....
May 12, 2010
US & Canadian companies
Merck to buy Millipore in $7.2bn deal
...Pfizer last year paid $68bn to acquire its smaller US rival Wyeth, while Abbott Laboratories of the US bought Solvay of Belgium’s pharmaceuticals business for $6.5bn....
February 28, 2010
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
UK companies
Grandma knows best when it comes to drugs
...Forest Laboratories’ UK division bought the Bisodol brand of indigestion products from Wyeth in 2004 and acquired the 70-year old nappy-rash treatment Sudocrem when it bought the Irish company Tosara in...
November 14, 2009
European companies
Abbott in €4.5bn deal for Solvay drug unit
...Abbott Laboratories on Monday announced the €4.5bn ($6.6bn) acquisition of Solvay’s pharmaceutical company, bringing a five-month takeover battle to an end and highlighting continued consolidation in the...
September 28, 2009
Construction sector
TTP ‘blunders’ into product manufacture
...The machines are normally sold to pharmaceutical companies or academic laboratories and rely on an eclectic range of technologies, including pneumatic control, chemicals know-how and mechanical engineering...
December 30, 2009
News in-depthThe Big Read
Health: No room for gloom
...Although prescriptions are rising, their value is falling as the new generation of antidepressants introduced during the 1980s and 1990s, such as Eli Lilly’s Prozac and Wyeth’s Effexor, lose their patent...
June 14, 2010
US & Canadian companies
Battle for Solvay division nears end
...The Swiss company is 41 per cent owned by Nordic Capital, the Swedish buy-out group....
September 24, 2009
FT AlphavilleGwen Robinson
Vaccines give a boost to pharma M&A
...Monday’s deals follow Pfizer’s agreement earlier this year to acquire Wyeth, what the Journal terms one of the relatively few big pharma companies known for its vaccine expertise....
September 29, 2009
European banks
Who’s buying whom?
...GlaxoSmithKline has focused on periodic “bolt-on” acquisitions, whether paying $4bn to buy Stiefel Laboratories, the US dermatology company, or purchasing the rights to rivals’ product portfolios in specific...
March 17, 2010
US & Canadian companies
Solvay whittles bidders down to two
...Solvay has whittled down the list of bidders for its pharmaceuticals business to Nycomed, the privately held Swiss company, and Abbott Laboratories of the US....
July 14, 2009
LexPharmaceuticals sector
GlaxoSmithKline/Stiefel
...Cost cutting in the wake of recent deals, such as Pfizer’s $68bn purchase of Wyeth and Merck’s $41bn takeover of Schering-Plough, will help offset the fall in revenues as drug patents expire....
April 20, 2009
US & Canadian companies
GSK agrees $3.6bn Stiefel purchase
...GlaxoSmithKline, the pharmaceutical group, has agreed to pay up to $3.6bn (£2.5bn) for Stiefel Laboratories of the US, significantly boosting its presence in dermatology as part of a growing portfolio of...
April 20, 2009

Previous pagePage 1 of 2Next page